Board logo

subject: Aarkstore Enterprise --- Intelgenx Technologies Corp. (igxt) - Financial And Strategic Analysis [print this page]


Aarkstore announce a new report " IntelGenx Technologies Corp. (IGXT) - Financial and Strategic Analysis Review" through its vast collection of market research report.

IntelGenx Technologies Corp. (IntelGenx) is a publicly held drug delivery company. It is engaged in the development of therapeutics using orally administered drug delivery systems for the treatment of pain, hypertension, osteoarthritis and depressive disorders. The company has developed two delivery platform technologies consisting of multilayer tablet technology, and oral drug delivery systems including an oral film technology and a mucoadhesive tablet technology. The oral controlled release pipeline products developed by the company include CPI-300, an antidepressant and INT0001, an advanced generic product involving Multilayer Technology.

IntelGenx Technologies Corp. Key Recent Developments

Mar 11, 2010: IntelGenx Receives Bupropion Patent

Jan 25, 2010: IntelGenx Seals Manufacturing Partnership With LTS

Nov 17, 2009: IntelGenx Presents Positive Bioequivalence Results With Novel Anti-Migraine Film

Aug 21, 2009: IntelGenx Provides Information On Bovail Patent Infringement Complaint

May 13, 2009: IntelGenx Posts Revenue Of $0.2 Million In Q1 2009

This comprehensive SWOT profile of IntelGenx Technologies Corp. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of IntelGenx Technologies Corp., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit:

http://www.aarkstore.com/reports/IntelGenx-Technologies-Corp-IGXT-Financial-and-Strategic-Analysis-Review-47267.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

by: Aarkstore Enterprise




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)